Patients in the United Kingdom are less likely to survive cancer five years after diagnosis than in Australia

Patients diagnosed with cancer in 2014 were more likely to survive in Australia than in the UK across multiple types of cancer. This is despite both countries having similar socio-economic conditions, allocating a comparable amount per person to healthcare, and having a similar share of their populations living with cancer.

For colorectal cancer, 71% of Australian patients survived five years after diagnosis, compared to 60% in the UK.

Lung, liver, and pancreatic cancers, which are among the most aggressive, also had lower survival rates in the UK.

The survival gap was most dramatic for pancreatic cancer patients, where Australia's 14% five-year survival rate was nearly double the UK's 8%.

These survival rates only account for diagnosed patients, meaning early detection and prompt treatment access significantly impact outcomes. Differences in healthcare systems, screening coverage, treatment approaches, and other health risk factors may contribute to the gap.

Explore how cancer survival rates compare across other countries →

Where this page came from

This page was imported from Our World in Data. “Patients in the United Kingdom are less likely to survive cancer five years after diagnosis than in Australia” by Veronika Samborska, published by Our World in Data under CC BY 4.0. Changed here: set as a page, its interactive charts shown as pictures. Data from third parties keeps its own licence.

Nobody has written it yet — it is the source material at a new address, which is why search engines are asked to skip it and why no one earns from it. It is up for grabs: take it on, and it is yours to rewrite and to earn from.